Nuvectis pharma announces proposed public offering of common stock
Source: SeekingAlpha
2025-02-04 16:18:50 ET
More on Nuvectis Pharma
- Nuvectis Pharma: Still Flat, Although There May Be A Ground Floor Here
- Nuvectis sinks after early-stage data for ovarian cancer therapy
- Seeking Alpha’s Quant Rating on Nuvectis Pharma
- Historical earnings data for Nuvectis Pharma
- Financial information for Nuvectis Pharma
Read the full article on Seeking Alpha
For further details see:
Nuvectis pharma announces proposed public offering of common stock
Nuvectis Pharma Inc.
NASDAQ: NVCT
NVCT Trading
2.15% G/L:
$8.09 Last:
13,688 Volume:
$8.09 Open:
NVCT Latest News
February 11, 2026 07:30:00 am
Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights
NVCT Stock Data
$223,874,191
14,667,089
29.18%
19
N/A
Biotechnology & Life Sciences
Healthcare
US
Fort Lee
